BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7389204)

  • 21. Induction and regulation by monokines of hepatic synthesis of the mouse serum amyloid P-component (SAP).
    Le PT; Mortensen RF
    J Immunol; 1986 Apr; 136(7):2526-33. PubMed ID: 3512716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of hepatic acute-phase protein transcripts: differential effects of acute and subchronic dimethylnitrosamine exposure in vivo.
    Lockwood JF; Rutherford MS; Myers MJ; Schook LB
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):288-95. PubMed ID: 7513450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine amyloid protein AA in casein-induced experimental amyloidosis.
    Skinner M; Shirahama T; Benson MD; Cohen AS
    Lab Invest; 1977 Apr; 36(4):420-7. PubMed ID: 403374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid phase enzyme immunoassays for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute-phase mouse sera.
    Taktak YS; Stenning B
    Horm Metab Res; 1992 Aug; 24(8):371-4. PubMed ID: 1526624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes.
    Baltz ML; Dyck RF; Pepys MB
    Immunology; 1980 Sep; 41(1):59-66. PubMed ID: 7000694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some effects of the administration of endotoxin in mice. Specific cleavage of serum albumin by an acid protease and the generation of amyloid serum component.
    Gorevic PD; Levo Y; Chatpar PC; Frangione B; Franklin EC
    J Clin Invest; 1979 Feb; 63(2):254-61. PubMed ID: 34628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute phase serum proteins in syngeneic and allogeneic mouse pregnancy.
    Waites GT; Bell AM; Bell SC
    Clin Exp Immunol; 1983 Jul; 53(1):225-32. PubMed ID: 6409477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains.
    Zahedi K; Gonnerman WA; Debeer FC; Debeer MC; Steel DM; Sipe JD; Whitehead AS
    Inflammation; 1991 Feb; 15(1):1-14. PubMed ID: 1711511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
    Maeda S
    Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloidosis in (CBA/J X A/J)F2 mice: correlation of amyloid resistance and low mitogenic response to concanavalin A.
    Wohlgethan JR; Cathcart ES
    J Immunol; 1981 Sep; 127(3):1003-7. PubMed ID: 7264297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response.
    Brandwein SR; Sipe JD; Tatsuta E; Skinner M; Cohen AS
    J Rheumatol; 1984 Oct; 11(5):597-601. PubMed ID: 6334740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.
    Baltz ML; Dyck RF; Pepys MB
    Clin Exp Immunol; 1985 Jan; 59(1):235-42. PubMed ID: 3882285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine.
    Le PT; Muller MT; Mortensen RF
    J Immunol; 1982 Aug; 129(2):665-72. PubMed ID: 6806378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating amyloid-related component in casein-induced murine amyloidosis.
    Baumal R; Sklar S
    J Rheumatol; 1977; 4(3):223-30. PubMed ID: 926100
    [No Abstract]   [Full Text] [Related]  

  • 36. Colchicine inhibition of the first phase of amyloid synthesis in experimental animals.
    Keizman IK; Greenwald M; Ravid M
    Br J Exp Pathol; 1976 Dec; 57(6):686-8. PubMed ID: 1008998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the acute phase response in the Shwartzman phenomenon.
    Pepys MB; Rogers SL; Evans DJ
    Clin Exp Immunol; 1982 Feb; 47(2):289-95. PubMed ID: 7042139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin biosynthesis in myeloma-associated and casein- and endotoxin-induced murine amyloidosis.
    Baumal R; Ackermann A; Wilson B
    J Immunol; 1975 Jun; 114(6):1785-91. PubMed ID: 1092761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
    Benson MD; Kleiner E
    J Immunol; 1980 Feb; 124(2):495-9. PubMed ID: 6985931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.